70
Participants
Start Date
December 17, 2020
Primary Completion Date
October 25, 2021
Study Completion Date
October 25, 2021
Sargramostim
250 μg/vial of sargramostim will be dissolved in 4 mL of physiological saline and 125 μg of which will be administered using inhaler twice daily in approximately 10-15 minutes.
Placebo
2 mL of physiological saline will be administered using inhaler twice daily in approximately 10-15 minutes.
IUHW Narita Hospital, Narita
Kanagawa Cardiovascular and Respiratory Center, Yokohama
Japanese Red Cross Society Saitama Red Cross Hospital, Saitama
St. Luke's International Hospital, Chuo-ku
Mishuku Hospital, Meguro-ku
Japanese Red Cross Medical Center, Shibuya-ku
Center Hospital of the National Center for Global Health and Medicine, Shinjuku-Ku
Lead Sponsor
Nobelpharma
INDUSTRY